Impaired Antibody Response Causes Persistence of Prototypic T Cell-Contained Virus

2009 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Impaired Antibody Response Causes Persistence of Prototypic T Cell-Contained Virus​
Bergthaler, A.; Flatz, L.; Verschoor, A.; Hegazy, A. N.; Holdener, M.; Fink, K. & Eschli, B. et al.​ (2009) 
PLoS Biology7(4) art. e1000080​.​ DOI: https://doi.org/10.1371/journal.pbio.1000080 

Documents & Media

Bergthaler.pdf190.96 kBAdobe PDF

License

Published Version

Attribution 2.5 CC BY 2.5

Details

Authors
Bergthaler, Andreas; Flatz, Lukas; Verschoor, Admar; Hegazy, Ahmed N.; Holdener, Martin; Fink, Katja; Eschli, Bruno; Merkler, Doron; Sommerstein, Rami; Horvath, Edit; Fernandez, Marylise; Fitsche, Andre; Senn, Beatrice M.; Verbeek, J. Sjef; Odermatt, Bernhard; Siegrist, Claire-Anne; Pinschewer, Daniel D.
Abstract
CD8 T cells are recognized key players in control of persistent virus infections, but increasing evidence suggests that assistance from other immune mediators is also needed. Here, we investigated whether specific antibody responses contribute to control of lymphocytic choriomeningitis virus (LCMV), a prototypic mouse model of systemic persistent infection. Mice expressing transgenic B cell receptors of LCMV-unrelated specificity, and mice unable to produce soluble immunoglobulin M (IgM) exhibited protracted viremia or failed to resolve LCMV. Virus control depended on immunoglobulin class switch, but neither on complement cascades nor on Fc receptor gamma chain or Fc gamma receptor IIB. Cessation of viremia concurred with the emergence of viral envelope-specific antibodies, rather than with neutralizing serum activity, and even early nonneutralizing IgM impeded viral persistence. This important role for virus-specific antibodies may be similarly underappreciated in other primarily T cell-controlled infections such as HIV and hepatitis C virus, and we suggest this contribution of antibodies be given consideration in future strategies for vaccination and immunotherapy.
Issue Date
2009
Status
published
Publisher
Public Library Science
Journal
PLoS Biology 
ISSN
1544-9173

Reference

Citations


Social Media